Analysis of the gene expression of sparc and its prognostic value for bladder cancer

Journal of Urology

Volumn 166, Issue 6, 2001, Pages 2495-2499

  Yamanaka, Masahito ^a   Kanda, Kazuya ^a   Li, Ning Chen ^a   Fukumori, Tomoharu ^a   Oka, Natsuo ^a   Kanayama, Hiro Omi ^a   Kagawa, Susumu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Bladder; Bladder neoplasms; Disease progression; Gene expression; Osteonectin; Prognosis

Indexed keywords

OSTEONECTIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CYSTOURETHROGRAPHY; DIAGNOSTIC VALUE; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035165052     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65623-6     Document Type: Article

References (21)

1. The biology of SPARC, a protein that modulates cell-matrix interactions
2. Extracellular protein that modulates cell-matrix interactions. SPARC, tinascin and thrombospondin
3. SPARC, a secreted protein associated with morphogenesis and tissue remodelling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway
4. Regulation of human monocyte matrix metalloproteinases by SPARC
5. Terms of attachment: SPARC and tumorigenesis
6. Distribution of SPARC in normal and neoplastic tissue
7. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer
8. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes
9. Overexpression of the stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: Implication for prognosis
10. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells
11. SPARC: A potential diagnostic marker of invasive meningiomas
12. Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma
13. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells
14. Molecular analysis of the cDNA for human SPARC/osteonectin/BM-40: Sequence, expression, and localization of the gene to chromosome 5q31-q33
15. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer
16. SPARC is a source of copper-binding peptides that stimulate angiogenesis
17. Superficial bladder cancer: Progression and recurrence
18. Invasive bladder cancer: Tumor configuration, lymphatic infiltration and survival
19. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines